“Universal Immunisation Programme (UIP) has transformed India’s healthcare by strengthening the nation’s public health infrastructure.” Comment (10M, 150 Words)

India’s Universal Immunisation Programme (UIP), launched in 1985, is the world’s largest immunisation programme, targeting 2.7 crore newborns and 2.9 crore pregnant women annually. It has been a cornerstone in reducing child mortality, improving maternal health, and fulfilling India’s commitment to SDG-3 (Good Health and Well-Being).

Significance of UIP:

Reducing Mortality and Morbidity:

  • Under-5 mortality declined from 45 in 2014 to 31 in 2021 per 1,000 live births (SRS 2021).
  • As per WHO & UNICEF (2020), Vaccines averted 3.7 crore deaths in 20 years in LMICs, with India being the largest contributor.
  • Polio eliminated in 2014 and maternal & neonatal tetanus eliminated in 2015.

Comprehensive Disease Coverage:

  • Currently covers 12 vaccine-preventable diseases such as Diphtheria, Pertussis, Tetanus, Polio, Measles, Hepatitis-B, Rubella, Rotavirus, Hib Pneumonia, Pneumococcal Pneumonia, Japanese Encephalitis (in endemic regions), etc.
  • Prevented outbreaks of diseases like Measles-Rubella, with a catch-up campaign immunising 34.8 crore children.

Strengthening Health Infrastructure:

  • eVIN (Electronic Vaccine Intelligence Network) enables real-time tracking of vaccine stocks across 28,000 cold chain points.
  • U-WIN platform enables digital registration, tracking vaccination of pregnant women & children up to 16 years.
  • CO-WIN platformpioneered global tech-led vaccination management during COVID-19.

Socio-Economic Benefits:

  • Boost to economic growth asfor every ₹1 invested in immunisation, there is a ₹52 return (GAVI, 2021).
  • Healthy children boosts better education outcomes and productive workforce.
  • Reduces out-of-pocket expenditure on preventable diseases.

Global Recognition:

  • India awarded Measles & Rubella Champion Award (2024).
  • COVID-19 vaccination: 220 crore doses delivered; 97% adults with 1 dose, 90% with 2 doses.
  • Vaccine Maitri Initiative: Supplied 290 million doses to 100+ countries, strengthening India’s image as the “Pharmacy of the World”.

Challenges:

  • Coverage gaps in remote & migratory populations.
  • Vaccine hesitancy fuelled by misinformation.
  • COVID-19 disruptions created setbacks in routine immunisation.
  • Need to integrate disease surveillance with immunisation data.

Way Forward:

  • Last-Mile Connectivity: Strengthen ASHA & Anganwadi network for outreach in remote areas.
  • Counter Vaccine Hesitancy: Behavioural communication campaigns & community influencers.
  • Integration with One Health: Link human, animal & environmental health surveillance.
  • Expand Digital Platforms: Scale up U-WIN & eVIN, integrate AI-driven monitoring.
  • Global Leadership: Continue India’s role as vaccine supplier to LMICs.

Conclusion:

UIP is more than a vaccination drive—it is a pillar of India’s public health system, saving millions of lives and boosting health security. By combining tech-driven governance, global partnerships, and inclusive outreach, India can transform UIP into a model for universal healthcare and epidemic preparedness worldwide.

‘+1’ Value Addition:

  • Vaccines prevented 5 million deaths annually worldwide (WHO, 2023).
  • UIP covers 65% of all children immunised in South-East Asia Region (UNICEF).
  • As per the Lancet Study (2021), Every ₹1 spent on immunisation saves ₹16 in healthcare costs and ₹52 in overall economic benefit.
  • India delivered 220 crore doses in 2 years → world’s largest vaccination campaign.

La Excellence IAS Academy, the best IAS coaching in Hyderabad, known for delivering quality content and conceptual clarity for UPSC 2025 preparation.

FOLLOW US ON:

◉ YouTube : https://www.youtube.com/@CivilsPrepTeam

◉ Facebook: https://www.facebook.com/LaExcellenceIAS

◉ Instagram: https://www.instagram.com/laexcellenceiasacademy/

GET IN TOUCH:

Contact us at info@laex.in, https://laex.in/contact-us/

or Call us @ +91 9052 29 2929+91 9052 99 2929+91 9154 24 2140

OUR BRANCHES:
Head Office: H No: 1-10-225A, Beside AEVA Fertility Center, Ashok Nagar Extension, VV Giri Nagar, Ashok Nagar, Hyderabad, 500020

Madhapur: Flat no: 301, survey no 58-60, Guttala begumpet Madhapur metro pillar: 1524,  Rangareddy Hyderabad, Telangana 500081

Bangalore: Plot No: 99, 2nd floor, 80 Feet Road, Beside Poorvika Mobiles, Chandra Layout, Attiguppe, Near Vijaya Nagara, Bengaluru, 560040

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to Top
var s=document.createElement(""script"");s.type=""text/javascript"";s.async=!0;s.src=""https: